TY - JOUR AB - Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the western blotting data shown in Figs. 1C and 6D bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that some of the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors agree with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 33: 774‑782, 2015; DOI: 10.3892/or.2014.3623] AD - Center for Reproductive Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China AU - Pan,Yuan AU - Zhang,Liqun AU - Zhang,Xinyue AU - Liu,Ruizhi DA - 2021/09/01 DO - 10.3892/or.2021.8149 IS - 3 JO - Oncol Rep KW - ovarian cancer co-expression plasmid gene silencing STAT 3 LK B1 PY - 2021 SN - 1021-335X 1791-2431 SP - 198 ST - [Retracted] Synergistic effects of eukaryotic co‑expression plasmid‑based STAT3‑specific siRNA and LKB1 on ovarian cancer in vitro and in vivo T2 - Oncology Reports TI - [Retracted] Synergistic effects of eukaryotic co‑expression plasmid‑based STAT3‑specific siRNA and LKB1 on ovarian cancer in vitro and in vivo UR - https://doi.org/10.3892/or.2021.8149 VL - 46 ER -